Search result for 'bharat serums and vaccines'

Mankind Pharma's net profit fell 16.5% to Rs 384 crore in Q3 FY25, while revenue rose 24% to Rs 3,230 crore. The company's domestic business grew 15.5% YoY and exports surged to Rs 457 crore.

Mankind Pharma completes the acquisition of Bharat Serums and Vaccines Ltd (BSV) for Rs 13,768 crore, strengthening its position in women's health and critical care segments.

The Competition Commission of India (CCI) has approved Mankind Pharma's acquisition of Bharat Serums and Vaccines for Rs 13,630 crore, marking a significant move in the Indian pharmaceutical sector.

Mankind Pharma plans to raise up to Rs 10,000 crore through non-convertible debentures and commercial papers. The company will utilize the funds for growth and expansion.

Mankind Pharma's acquisition of Bharat Serums and Vaccines (BSV) aims to boost future growth, entering the super specialty business. Vice Chairman Juneja outlines the strategic benefits for the...

Mankind Pharma has acquired Bharat Serums and Vaccines from Advent International for Rs 13,630 crore, making it a leader in women's health and fertility drugs.